Spain launches Aspen Pharma probe
Spain’s National Authority for Markets and Competition last week began an investigation of South African drugmaker Aspen Pharma and its Spanish distributor for allegedly restricting the supply and fixing the price of several pharmaceuticals.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.